USOG, AGRT, VGPR, BMGP, LUXED, ALKN, DNAG, IOVE, KKUR, SNSS, MESA OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, January 6th

Our Stocks to Watch today include United States Oil & Gas Corp. (OTC: USOG), AGR Tools Inc. (OTCBB: AGRT), Vega Promotional Systems Inc. (OTC: VGPR), Biomagnetics Diagnostics Corp. (OTC: BMGP), Lux Energy Corp. (OTCBB: LUXED), Alkane Inc. (OTC: ALKN), DNAPrint Genomics Inc. (OTCBB: DNAG), Accredited Business Consolidators/Italian Oven Corp. (OTC: IOVE), ChromoCure Inc. (OTC: KKUR), Sunesis Pharmaceuticals Inc. (Nasdaq: SNSS) and Mesa Air Group Inc. (Nasdaq: MESA).

 

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.

 

UNITED STATES OIL & GAS CORPORATION (OTC: USOG)

"Up 4.62% up in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/USOG.php

 

Company Profile: http://www.otcpicks.com/us-oil-and-gas.htm 

 

United States Oil & Gas Corp. is focused on the domestic oil and gas services sector, acquiring oil and gas services companies with historically profitable results, strong balance sheets, high profit margins, and solid management teams in place. USOG also develops innovative technologies to increase oil and gas extraction with the smallest environmental footprint.

 

USOG News:

 

January 6 - United States Oil & Gas Corporation Closes Acquisition of North Dakota Services Company; to Take Advantage of Proximity to Bakken Formation; Existing Propane Customer Sales Growth Expected to Double

 

United States Oil & Gas Corporation (OTC: USOG), a growing oil and gas products, services and technology company, is pleased to announce that it has closed its acquisition of United Oil ("United"), a profitable North Dakota-based distributor of refined fuels and other oil-based products. United, along with Turnbull Oil, which USOG purchased in May 2009, is now a wholly owned operating subsidiary of USOG. The purchase was made using a combination of cash, stock and promissory note.

 

During 2010, the Company will explore available efficiencies from the combined operations with Turnbull. CEO, Alex Tawse commented, "One of our competitive strengths is that our management possesses a unique experience and skill set with improvement of operational efficiencies. We will utilize that strength to lower costs and increase profit."

 

In addition, there is also significant opportunity for growth through marketing both at the local level and through the increased exposure that comes with being a public company. Notwithstanding the fact that to date United has done very little to no advertising or direct marketing, revenue is expected to total $8 million for the year ending December 31, 2009, with steady growth moving forward. Revenue for 2008 totaled $7 million, to-date the company's best on record. More details of United's earnings will be provided after the quarter ends.

 

Importantly, the Bakken Formation discovery in North Dakota, with its estimated 500 billion barrels of accessible oil, the largest since Alaska's Prudhoe Bay, significantly improves the economic landscape for the area. United is well positioned to take advantage of the increased demand for fuel that will come from additional prospecting and drilling that is forecasted.

 

Last year, United signed 156 new propane customers, 65 of which were added in the fourth quarter alone. During 2010, the company expects to deliver 700,000 gallons of propane to its existing customer base. This represents a 54% increase over sales during 2009. On a dollar basis it equates to approximately $1.25 million of revenue at today's prices.

 

As the price of propane has increased materially in recent months, United has also benefited from the summer purchase of forward hedges for a significant portion of its propane supply. Now selling at around $1.80 per gallon in N. Dakota, propane prices have risen to over 90% since the summer.

 

As previously reported, USOG's purchase of United includes all property, equipment and six acres of developable land. Besides United Oil and Gas, Inc., United Propane, United C-Store and an additional gas station and C-store that will soon be operational are part of the acquisition.

 

Management, which has over 30 years experience in the industry, is contracted to remain with the business for a minimum of three years. The company was started in 2003, and includes a bulk storage plant, and a fleet of tanker trucks.

 

Located in the northern central portion of North Dakota, United is a profitable oil and gas distribution company which sells diesel, race gasoline, propane, and lubricants to over 400 customers including regional businesses, farms, and private residences. The company offers personal customer service and premium pricing; comparative advantages that have helped attract new customers and increase market share.

 

AGR TOOLS INCORPORATED (OTCBB: AGRT)

 

Detailed Quote: http://www.otcpicks.com/quotes/AGRT.php 

 

Company Profile: http://www.otcpicks.com/agr-tools.htm

 

As a global leader in the manufacturing of high quality diamond tools, AGR Tools has been serving the construction and natural stone industries worldwide since 1983. AGR Stone & Tools USA, Inc. is the only manufacturer of a complete line of diamond tools designed for maximum performance for each application. Our products include turbo blades, polishing pads, cup wheels, core bits, tile blades, masonry blades, concrete blades, CNC tooling, engineered stone products and other high-end diamond tools.

 

AGRT News:

 

January 5 - Engagement of Auditor

 

AGR Tools Inc. (OTCBB: AGRT) announced that AGR Stone & Tools USA, Inc., with which AGR Tools, Inc. has entered into a binding share exchange agreement, engaged the services of Texas based M&K CPAs, PLLC for the auditing of the company's financial statements. One of the conditions to the closing of the share exchange agreement between AGR Tools, Inc. and AGR Stone & Tools USA, Inc. is that AGR Stone & Tools USA, Inc. provides audited financial statements for its last two years of operations. M&K CPAs, PLLC have been chosen to do the audit work and have begun their engagement.

 

The company anticipates that shortly after the audit of the financial statements has been completed, the share exchange transaction with AGR Stone & Tools USA, Inc. will close.

 

VEGA PROMOTIONAL SYSTEMS INCORPORATED (OTC: VGPR)

"Up 4.94% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/VGPR.php 

 

Company Profile: http://www.otcpicks.com/Newsletter/VGPR_eProfile_110909.html

 

Vega Biofuels, Inc. (VGPR) was formed to pursue the production and sale of biofuel products throughout the world. With the growing need for clean energy, and the uncertain costs of fossil fuels, power generating plants around the world are looking at more useful and economical methods to run their power systems.

 

VGPR News:

 

January 5 - Vega's Green Valley Project to Restart Power Production

 

Vega Promotional Systems, Inc. (OTC: VGPR) announced the Company's Green Valley Project will restart the production of power.

 

The Company recently hosted a meeting at the Western Indiana production facility that included Officers and Engineers from the Company and various equipment and service vendors. Subsequent to the meeting, the Company has ordered a gas flow analysis that will be conducted on the existing wells to determine if it is necessary to drill additional wells. The Company's plan is to stage the installation of the new generator sets and plans to restart the power production facility by installing the first generator and utilizing the methane from the existing well as stage one.

 

Stage two will include drilling at least one additional well and running a new supply line from the Green Valley Mine to a planned second generator to be installed at the production facility. The Company's plan is to have the first generator in place within the next few weeks.

 

"It was great to have everyone at the facility," stated Vega Chairman, Michael K. Molen. "We are looking forward to installing the new generators and restarting the Green Valley Project. It is a very exciting and complex power project. We have a few photographs from the facility and will have them posted on our web site within the next few days. We'll also have an announcement about the generator installation in the coming days."

 

Located in western Indiana, The Green Valley Project is a multifaceted green energy power production facility that converts inexpensive methane gas from the abandoned Green Valley Mine into electricity and thermal energy.

 

The methane has been tested and a demonstration project was in operation for approximately three years, proving the viability of utilizing coal bed methane from the Mine as a sole source fuel to generate electricity from natural gas reciprocating engine generator sets.

 

The Company will release additional details on The Green Valley Project as the project moves forward.

 

BIOMAGNETICS DIAGNOSTICS CORPORATION (OTC: BMGP)

 

Detailed Quote: http://www.otcpicks.com/quotes/BMGP.php  

 

Company Profile: http://www.otcpicks.com/biomagnetics-diagnostics/biomagnetics-diagnostics.htm

 

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company's revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies.

 

BMGP News:

 

December 28 - Biomagnetics to Become Fully Reporting; CEO Comments on Corporate Growth Plans and Strength of Balance Sheet

 

Biomagnetics Diagnostics Corp. (OTC: BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, announced it is instituting several actions to become a fully reporting organization, improve transparency to investors and migrate the trading of its common shares to the over-the-counter market. Additionally, corporate management is expressing confidence in achieving growth objectives for 2010.

 

“With the growth we expect during 2010 it will be important for us to provide full transparency to our investors and other stakeholders," commented Clayton Hardman, CEO of Biomagnetics Diagnostics. “Toward this aim, we have begun implementing plans to complete a full financial audit and to file these audit results with both Pink OTC Markets, Inc. and the Securities and Exchange Commission. We expect these actions to allow us to not only become a fully reporting organization, but also to make us eligible to trade our shares on the OTC market.

 

These actions include the completion of a full financial audit and the filing of financial disclosure information with Pink OTC Markets Inc. and the U.S. Securities and Exchange Commission. Additionally, the Company will be working with several broker-dealers on Rule 15c2-11 documentation for submission to FINRA in order to receive OTCBB quotation clearance.

 

“Our balance sheet remains very strong with a meaningful cash balance and minimal debt. We have been able to accomplish this with only very minimal fund-raising activities. This has allowed us to keep the number of total outstanding shares at only approximately 64 million. While we do not anticipate the need to raise growth capital, as our working capital balances are already robust, it is very comforting for us to have the strong backing of our shareholders, many of whom are eager to provide us additional growth capital should it be required. Simply put - our financial position is very strong, which will allow us to aggressively implement our growth strategies. With a total market capitalization of approximately $9 million, we believe our common shares are significantly undervalued.”

 

“Mr. Hardman continued, “While we realized significant accomplishments in the last four months of 2009, we expect the acceleration of developments in the first half of 2010. During the first quarter, we expect to enter into several certifications in China, India and Africa, which we believe will clearly demonstrate the superiority of our technology and testing cost profile relative to the inferior solutions currently available in today's market. In the first half we expect to expand upon our groundbreaking agreement with Los Alamos National Security, commercialize the integrated optical biosensor technology for the detection of cholera, malaria, tuberculosis and HIV/AIDS, in addition to accelerating development of the technology that will enable multiple detections from a single sample. We are clearly very excited about where Biomagnetics Diagnostics is headed during 2010.”

 

According to the World Health Organization, some 3.2 billion people, or about half the world's population is at risk of malaria transmission in 107 countries and territories worldwide. While there are between 350 million and 500 million new cases of malaria each year, there are very few reliable and field deployable diagnostic tools available. In the case of malaria, early detection substantially improves treatability and survivability. Field deployable Integrated Optical Biosensor Systems (IBOS), such those Biomagnetics Diagnostics is planning to soon introduce hold the promise to significantly speed the diagnostic testing process and to meaningfully lower costs and improve lives.

 

LUX ENERGY CORPORATION (OTCBB: LUXED)

 

Detailed Quote: http://www.otcpicks.com/quotes/LUXED.php 

 

Company Profile: http://www.otcpicks.com/lux-energy-corp/lux-energy-corp.htm

 

Lux Energy Corp. is an oil and gas production and exploration company focusing on developing oil and gas resources in North America. Further information and news releases are available at www.luxenergycorp.com.

 

LUXED News:

 

December 16 - Lux Energy Corp Enters Into Negotiations for Participation in Significant Natural Gas Prospect

 

Lux Energy Corp. (OTCBB: LUXED), an oil and gas production and exploration company, announced that it has entered into negotiations to participate in significant natural gas prospect in South Eastern Alberta. Lux is seeking an agreement for a 50% working interest in eight development NG leases in the sweet gas rich areas of Medicine Hat.

 

Southern Alberta gas plays have produced thousands of wells over the past several decades. This area is historically famous in oil and gas circles for low cost, high BTU content reservoirs in the Milk River and Medicine Hat geological formations. The arena of petroleum spans 10,000 square kilometers of Sandstone Geology starting at the Foothills and stretching into Saskatchewan.

 

The prospect will involve a drilling program of 20 to 30 wells per section drilled to depths of 800 meters. Reservoir life is estimated at between 13 to 30 years. The project has outstanding economies. Wells can be drilled, completed and tied into established gathering, processing and delivery infrastructure within 30 days. In addition, the joint venture operator advises that recent technical advances in this play have increased potential recoveries and increased production.

 

Shane Broesky, President of Lux Energy Corp, comments, "Medicine Hat is an exceptional opportunity which became available with our partners in other areas. Medicine Hat, Central Alberta, Northern B.C. and Oklahoma are all on the screen. We intend to take advantage of the recent upsurge in NG prices. Recent acquisitions by petroleum super majors indicate very strong future natural gas products."

 

Lux Energy Corp. is an oil and gas production and exploration company focusing on developing oil and gas resources in North America. Further information and news releases are available at www.luxenergycorp.com.

 

ALKANE INCORPORATED (OTC: ALKN)

"Up 145.40% in morning trading"

 

Company Profile: http://www.otcpicks.com/alkane-inc.htm 

 

Alkane, Inc. is dedicated to the development and sales of alternative fuels and additives which reduce the cost of operating and maintaining vehicles. Additional benefits of Alkane, Inc.'s product offerings include positive environmental impact through the reduction of harmful emissions and a lessened U.S. dependence on foreign oil due to a decrease in crude oil dependent diesel fuel consumption.

 

ALKN News:

 

October 21 - Dr. Mathew Zuckerman of Alkane, Inc. Receives The Daily Record's 2009 Maryland Innovator of the Year Award

 

Mathew Zuckerman, Ph.D. of Alkane, Inc. (OTC: ALKN) ("Alkane") has been selected as a winner of The Daily Record's 2009 Innovator of the Year Awards.

 

The Daily Record began the Innovator of the Year Awards in 2002 as a way to recognize Marylanders and Maryland-based companies for their innovative spirit - for creating new products, new programs, new services, or new processes that have helped their companies, industries, or communities.

 

"I am honored to have been recognized for my work on Alkane's flagship product, Monster Diesel™," said Zuckerman, who is President & CEO of Alkane, as well as Inventor of patent pending technology on which the Monster Diesel™ product is based. "We have a product that increases diesel fuel's power and MPG, lowers emissions, winterizes fuel, and reduces engine wear. It's just a matter of getting the word out to potential users. This recognition by The Daily Record helps us to do just that."

 

"The Daily Record's Innovators of the Year have imagination and vision, the ability to see a need and fill it, and the courage to make change happen," says Christopher Eddings, Publisher of The Daily Record. "We applaud Dr. Zuckerman for embodying the innovative spirit."

 

This year, The Daily Record received more than 80 nominations, which are solicited from The Daily Record's readers, economic development agencies, chambers of commerce, and the business community at large. Nominees are then asked to complete an application which explains their innovation and the impact it has made on Maryland.

 

A distinguished panel of judges reviewed the applications and selected 25 winners for 2009, including the top Innovator of the Year. The winners were honored on October 14 at a cocktail reception, held at Baltimore's American Visionary Art Museum. Winners also were profiled in a special magazine that was included in the October 16 issue of The Daily Record.

 

ABOUT THE DAILY RECORD

 

For 121 years, The Daily Record Company has provided trusted legal and business information to Maryland readers. In addition to the daily newspaper published five days a week, The Daily Record publishes its website, www.mddailyrecord.com, two blogs, On the Record and Eye on Annapolis, and a variety of special publications on topics of interest to Maryland business and legal professionals.

 

The Daily Record also honors leading Marylanders through events such as Influential Marylanders, Maryland's Top 100 Women, Leadership in Law and Health Care Heroes. The Daily Record is owned by Dolan Media Company, trading as DM, of Minneapolis, MN.

 

DNAPRINT GENOMICS (OTCBB: DNAG)

"Up 240.00% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/DNAG.php

 

DNAPrint Genomics, Inc. engages in the research and development of genomic products, and provides scientific services and tests to the genealogy, forensic, pharmaceutical, and genetics markets in the United States. Its primary product under development is PT-401, a "Super EPO" (erythropoietin) dimer protein drug for treatment of anemia in renal dialysis patients. The company's other products under development include PT-501 for the treatment of attention deficit hyperactivity disorder; PT-502 for the treatment of drug addiction; and PT-503 for the treatment of depression. DNAPrint Genomics also develops diagnostic tests, including OVANOME for ovarian cancer, STATINOME for the safety of statins, DIABETES-CD59 for pre-diabetes diabetic complications; and PONV for post-operative nausea and vomiting. In addition, it offers DNAWitness product suite for the forensics market to determine genetic heritage from DNA samples obtained from crime scenes; and ANCESTRYbyDNA and EURO-DNA, which are genealogy products that provide an inference of an individual's genetic ancestry or heritage. Further, the company provides sequencing and genotyping services to industrial customers. DNAPrint Genomics has strategic alliances with Moffitt Cancer Center, and Beth Israel Deaconess Medical Center; and a collaborative research agreement with Beth Israel. It also has a license agreement with Harvard Medical School, and a research sponsorship agreement with Massachusetts College of Pharmacy and Health Sciences. The company, formerly known as Lexington Energy, Inc., was incorporated in 1983 and is based in Sarasota, Florida.

 

DNAG News:

 

February 1 - Nanobac Pharmaceuticals Inc. Signs LOI for the Acquisition of DNAPrint Genomics

 

Nanobac Pharmaceuticals Inc. (OTCBB: NNBP) ("Nanobac" or "the Company”) announced a jointly signed letter of intent for the acquisition of DNAPrint Genomics, Inc. (OTCBB: DNAG) (“DNAPrint” or DNAP). With the acquisition, which is subject to DNAPrint Genomics shareholder approval, Nanobac becomes one of a select group of next-generation drug and diagnostics developers, applying advanced computational methods and systematic genome-based approaches to streamline clinical product development. Nanobac adds advanced drug and diagnostics development programs, key patents and patent applications, and a proprietary product modeling platform to its existing initiatives, and expands its focus into multiple disease sites for both Diagnostics and Therapeutics.

 

The combined company would have annualized revenue of approximately $5,000,000, developing drug pipeline and product development collaborations with Harvard/Beth Israel Deaconess Medical Center, Mayo Clinic, Cleveland Clinic and Emory University.

 

DNAPrint Genomics has developed, patented and published various technologies for an improved, 21st century model of clinical product development - aimed at maximizing effectiveness, minimizing unintended effects, reducing costs and shifting the risk to reward ratio during clinical product development. These tools include extensively validated and published genome assays for individualized assessments of genetic ancestry on multiple levels (consumer products segment), tools for the inference of physical characteristics for the forensics market, tools for the inference of patient proclivities to respond to treatments (pharmacogenomics) and meta-analytical systems for computationally modeling the biology of clinical products for a more intelligent approach to drug and diagnostic development. DNAG's primary objective has been, and Nanobac's primary objective will be, to develop progressive theranostics drugs, which combine extensively modeled drugs with genomics-derived intelligence to create more economical and powerful drug/test combination products with superior performance parameters. DNAG's flagship product, PT-401, is expected to result in more effective treatment of anemia, and its Protectin(TM) (CD-59) diagnostic test is expected to allow patients and their physicians to more effectively manage the risks and treatment decisions for diabetes. DNAG supports its clinical programs, in part, through the sale of consumer genetics tests genotyping services on a contractual basis.

 

“Dr Hector Gomez has been on the Company’s advisory board giving Nanobac the benefit of evaluating DNAG’s technologies and portfolio of products,” said Dr. Benedict Maniscalco, Co-Chairman and Chief Medical Officer of Nanobac Pharmaceuticals. “Combining our diagnostic portfolios, specifically DNAP’s Protectin™ and Nanobac’s NB2 has the potential to play a significant role in the early diagnosis of vascular disease and could potentially help in identifying early signs and progression of cardiovascular disease,” Dr. Maniscalco concluded.

 

"The Protectin(TM) test will be used to identify diabetics at risk of developing vascular complications," said Dr. Gomez, Chairman of DNAP. "Protectin(TM) is anticipated to become a new tool in the complex understanding of Diabetes and could potentially replace HbA1c, the current test used to evaluate glucose control. Combined with Nanobac's diagnostic portfolio, Protectin(TM) is expected to dramatically increase the physician's ability to diagnose patients at significant cardiovascular risk," concluded Dr. Gomez.

 

According to Global Industry Analysts, the international global diabetes diagnostic supplies market is expected to grow to US$15.4 billion by 2010. This indicates significant potential for the Protectin™ test. Additionally, cardiovascular diagnostics will see a high rate of growth also, increasing from $11.9 billion in 2007 to $21.4 billion by the end of 2012. The cardiovascular diagnostics market represents one of the largest sectors within the diagnostics industry, chiefly due to the high prevalence rate of and high mortality rate from cardiovascular disease.

 

DNAG’s flagship PT-401 therapeutic, in pre-clinical stages, is a genetically engineered erythropoietin dimmer (double form), which elicits a heartier, longer lasting increase in hematocrit for anemic patients. The singlet form of erythropoietin was introduced by Amgen Corporation in 1989, and enjoys a $2B in annual sales. A successfully approved PT-401 alternative is expected to allow physicians to treat patients with less drug and at less frequent intervals, at significant savings, while at the same time, increasing the consistency of therapeutic response.

 

Nanobac Pharmaceuticals is the leader in research and treatment of degenerative diseases stemming from nanobacterial infections. This infection is implicated in the formation of disease-causing calcification and plaque in the circulatory system and vital organs. Nanobac Pharmaceuticals markets diagnostics and prescription nanobiotic medications demonstrated to safely and effectively treat an underlying cause of atherosclerosis, coronary heart disease and other degenerative diseases.

 

Nanobac Pharmaceuticals Inc. is headquartered in Tampa, Florida. For more information, visit the company's website at www.nanobac.com.

 

ACCREDITED BUSINESS CONSOLIDATORS CORP. (OTC: IOVE)

"Up 9.76% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/IOVE.php

 

Accredited Business Consolidators Corp., formerly known as the Italian Oven, is a diversified holding corporation. Visit www.accreditedbiz.com (under construction) for information on its affiliated companies. The total number of common shares outstanding is 436,399,500. 328,018,200 shares are in the public float and on hand with CEDE & Co., 70,546,600 shares are restricted in certificate form, and 37,834,700 shares are unrestricted but in certificate form. There will be no increase in shares until at least April 2010.

 

IOVE News:

 

January 6 - Accredited Business Consolidators Corp. to Receive New Ticker Symbol

 

Accredited Business Consolidators Corp., trading as Italian Oven (OTC: IOVE) received information from the Financial Industry Regulatory Authority (FINRA) that it would receive its new symbol shortly. IOVE anticipates that it will occur either this week or the beginning of next week.

 

The Company appreciates the diligent work by FINRA staff in reviewing voluminous documents submitted by the Company. FINRA plays a crucial role in helping to assure that investors are not victimized by cases of corporate identity fraud in the over the counter market. In the case of IOVE, FINRA staff had to review a lengthy history of corporate documents.

 

The Company is pleased to have closed this chapter and it now looks forward to moving ahead with its stated plans.

 

CHROMOCURE INCORPORATED (OTC: KKUR)

"Up 42.86% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/KKUR.php

 

ChromoCure develops and provides proprietary cancer detection systems. The Company owns its technology and provides its systems on a revenue sharing basis. The Company's proprietary ChromoCure CS200 Chromosomal Scanner system measure the unique genomic characteristic found in 100% of all cancers and never found in normal cells. The Company believes its technology has an effective accuracy of 100% for all cancers at all stages. The Company believes its technology superior and will become the gold standard for cancer detection worldwide. The Company's technology and cancer expertise also suggest non-toxic and non-invasive approaches to cancer therapy and cure research. The Company will release progress reports on these initiatives from time to time.

 

KKUR News:

 

January 5 - ChromoCure Announces Mayo Clinic Research Confirms Its Technology and Chromosomal Basis of Cancer

 

ChromoCure, Inc. (OTC: KKUR) announced the basis for the Company's technology confirmed by recent Mayo Clinic researchers. Their findings, which appear in the current issue of the journal Cancer Cell, along with an independent commentary on the discovery, end a major controversy in the field of cancer research as to whether aneuploidy is a cause or a consequence of cancer and further proves the aneuploidy basis of cancer. The research may be accessed here:

 

www.cell.com/cancer-cell/fulltext/S1535-6108(09)00387-0

 

This recent publication enhances the company's international activities to promote its cancer detection system and related technology through its ChromoCure Cancer Research & Diagnosis Centers program. The research further confirms the chromosomal theory of cancer and immediately establishes the company's technology in the forefront of both cancer detection and research.

 

ChromoCure's proprietary CS200 Chromosomal Scanner system and related technology is specifically designed to target the unique chromosomal characteristics demonstrated in the Mayo Clinic research. Detecting the unique chromosomal signature of cancer yields an effectively 100% accurate method of detecting all forms of cancer at all stages.

 

The company's systems detect the single characteristic found in 100% of all cancers at all stages, and never found in normal cells. The company therefore believes its technology detects cancer with an effective 100% specificity and effective 100% accuracy. The Company's technology also objectively measures, with high precision, the level of cancer present and its stage of progression.

 

ABOUT MAYO CLINIC

 

Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of "the needs of the patient come first." More than 3,700 physicians, scientists and researchers, and 50,100 allied health staff work at Mayo Clinic, which has campuses in Rochester, Minn., Jacksonville, Fla. and Scottsdale/Phoenix, Ariz.; and community-based providers in more than 70 locations in southern Minnesota, western Wisconsin and northeast Iowa. These locations treat more than half a million people each year.

 

SUNESIS PHARMACEUTICALS INCORPORATED (NASDAQ: SNSS)

"Up 31.48% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/SNSS.php 

 

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer.

 

SNSS News:

 

December 28 - Sunesis Pharmaceuticals Regains NASDAQ Compliance

 

Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced that it has received notification from The NASDAQ Stock Market that it has regained compliance with the minimum $1.00 per share bid price requirement. As required under NASDAQ's Listing Rules, to regain compliance, the Company was required to evidence a closing bid price of $1.00 per share or more for at least ten consecutive days. On December 23, 2009, the closing bid price of the Company's common stock was $1.34 per share, the tenth consecutive day the stock price had closed above $1.00 per share.

 

MESA AIR GROUP INCORPORATED (NASDAQ: MESA)

"Up 14.36% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/MESA.php

 

Mesa Air Group, Inc., through its subsidiaries, provides scheduled passenger and airfreight services. It carries passengers, as well as freight and express packages on its passenger flights. The company also has interlined small cargo freight agreements with various other carriers. In addition, Mesa Air Group contracts with the U.S. Postal Service for carriage of mail to the cities it serves. Further, it occasionally operates charter flights. As of September 30, 2007, the company operated a fleet of 182 aircraft with approximately 1,100 daily departures to 184 cities in the United States, the District of Columbia, Canada, the Bahamas, and Mexico. Mesa Air Group was founded in 1980 and is headquartered in Phoenix, Arizona.

 

MESA News:

 

January 5 - Mesa Air Group Commences Restructuring

 

Files Voluntary Chapter 11 Petitions; Business Will Continue Unaffected

 

Mesa Air Group, Inc. (Nasdaq: MESA) (the “Company”) announced that it has commenced a financial restructuring through the voluntary filing of petitions to reorganize under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York (the “Court”). During the restructuring, the Company will continue to operate as normal, without interruption, which includes its code-share agreements with its partners US Airways, United Airlines and Delta Air Lines. Mesa’s go!-Mokulele joint venture, an independent Hawaiian inter-island operation, is not included in the filing and will continue to operate its full flight schedule.

 

“Founded in 1982, Mesa has grown from a company operating a single seven passenger airplane into one of the largest independent regional air carriers. We were one of the first airlines to operate regional jets and pioneered the “revenue guarantee” business model – both now standards in the industry. In 2005, Mesa was named ‘Regional Airline of the Year’. After careful consideration, the Company determined that a Chapter 11 filing provides the most effective and efficient means to restructure with minimal impact on the business and our customers. This process will allow us to eliminate excess aircraft to better match our needs and give us the flexibility to align our business to the changing regional airline marketplace, ensuring a leaner and more competitive company poised for future success,” said Jonathan Ornstein Chairman and Chief Executive of Mesa. “Over the past two years, we have worked closely with our lessors, creditors and other constituents to restructure our financial obligations. These efforts have led to the elimination of over $160 million of debt obligations, the return of a number of aircraft, and the restructuring of inventory management and engine overhaul agreements. We are nonetheless faced with an untenable financial situation resulting primarily from our continued lease obligations on aircraft excess to our current requirements. In addition, this action will give us the opportunity to reach a more timely conclusion in the litigation with Delta Air Lines in which Mesa is currently seeking damages in excess of $70 million.”

 

To ensure the Company operates without interruption, Mesa is seeking authority from the Court to continue all of its normal operations. The requests include authority to continue to pay employee salary and benefits, fulfill code-share partner agreements, honor customer programs, and pay vendors and suppliers for post-petition goods and services. These requests are standard and the Company anticipates receiving approval in the next few days. Vendor and supplier invoices incurred prior to the commencement of the Company’s Chapter 11 case that have not been paid will be resolved through the Company’s Plan of Reorganization which requires Court approval and has yet to be submitted.

 

“We remain committed to our partners and customers by providing continued low cost regional air service that has permitted Mesa to become a leading regional airline,” said Mr. Ornstein. “Our Company has ample liquidity to support itself during this process and we are confident we will emerge from Chapter 11 an even stronger operation. The foundation of our business – our people, operational integrity and values – remains intact, and the 20 plus years that many of us have worked together form a bond from which we will draw our strength as we face and overcome this challenge.”

 

Interested parties can find updates and additional information at the Company’s website at www.mesa-air.com/restructuring. Imperial Capital is serving as financial advisor, and Pachulski, Stang, Ziehl & Jones LLP is serving as legal counsel to the Company and its subsidiaries in connection with the restructuring.

 

Mesa currently operates 130 aircraft with approximately 700 daily system departures to 127 cities, 41 states, Canada, and Mexico. Mesa operates as Delta Connection, US Airways Express and United Express under contractual agreements with Delta Air Lines, US Airways and United Airlines, respectively, and independently as Mesa Airlines and go! Mokulele. This operation links Honolulu to the neighbor island airports of Hilo, Kahului, Kona and Lihue. The Company, founded by Larry and Janie Risley in New Mexico in 1982, has approximately 3,500 employees.

 

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org/.

Disclosure: OTCPicks.com has been compensated two thousand five hundred dollars by a third party (BlueWave Advisors) for USOG advertising and promotional services. OTCPicks.com has been compensated two thousand five hundred dollars by a third party (BlueWave Advisors) for AGRT advertising and promotional services. OTCPicks.com has not been compensated for VGPR advertising and promotional services but OTCPicks principles have purchased six hundred thousand free trading shares in the open market and reserves the right to sell any or all shares at any time. OTCPicks.com has been previously compensated seven thousand five hundred dollars by a third party for BMGP advertising and promotional services. OTCPicks.com has been compensated twelve thousand five hundred dollars by a third party for BMGP advertising and promotional services. OTCPicks.com has received three thousand dollars from a third party (Heritage First Capital) for LUXED advertising and promotional services. OTCPicks.com has been compensated two hundred and fifty thousand free trading shares by a third party (TEN Associates, LLC) for ALKN advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCPicks.com is a website partially owned by BlueWave Advisors, LLC, a financial public relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.